Jeffrey Eisenberg

Jeffrey Eisenberg

Plus aucun poste en cours
60 ans
Health Technology
Commercial Services
Consumer Services

Profil

Jeffrey F.
Eisenberg
worked as a Lawyer at Steel Hector & Davis LLP.
From 1995 to 1998, served as Associate General Counsel at IVAX LLC.
From 1998 to 2016, was with Noven Pharmaceuticals, Inc., including the role of President, Chief Executive Officer & Director from 2009 to 2016.
From 2007 to 2014, was President at Novogyne Pharmaceuticals.
From 2016 to 2018, was Independent Director at MabVax Therapeutics Holdings, Inc. Also held a Director position at MabVax Therapeutics, Inc. From 2017 to 2024, was Chief Executive Officer & Director at Xenetic Biosciences, Inc. Education includes graduate studies at Columbia Law School and undergraduate studies at The Wharton School of the University of Pennsylvania.

Anciens postes connus de Jeffrey Eisenberg

SociétésPosteFin
XENETIC BIOSCIENCES, INC. Directeur Général 16/05/2024
MABVAX THERAPEUTICS HOLDINGS, INC. Directeur/Membre du Conseil 31/07/2018
Directeur Général 01/01/2016
President 01/08/2014
Conseiller Juridique Général -
Voir l'expérience en détail de Jeffrey Eisenberg

Formation de Jeffrey Eisenberg

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

68

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Commercial Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Jeffrey Eisenberg
🔇